Companies: 10,795·Total market cap: $144.5T
Nano-X Imaging Ltd.

Nano-X Imaging Ltd.

NNOXNASDAQHealthcare● Active
$1.96
+$0.03(+1.30%)
Market Cap$136048896
P/E Ratio—
52W High$5.72
52W Low$1.59
Shares OutstandingFinancialsRevenue

Nano-X Imaging Ltd. (NNOX) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

NNOX · shares outstanding · updated Jun 8, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
64.8M▲ +10.52% YoY Change
FY · as of Dec 31, 2025 · Reported in USD
vs 58.6M in FY 2024
Diluted Shares Outstanding
64.8M
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+10.52%
year-over-year
Float (Free Float)
69.4M
publicly tradable shares
99.7% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-08

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+7.4%
2022 → 2025
5-Year CAGRincreasing
+12.7%
2020 → 2025
10-Year CAGR—
—
—
ⓘ

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2025Latest
Diluted Shares: 64.8M
64.8M
+10.52%
FY 2024
Diluted Shares: 58.6M
58.6M
+4.00%
FY 2023
Diluted Shares: 56.4M
56.4M
+7.91%
FY 2022
Diluted Shares: 52.2M
52.2M
+8.34%
FY 2021
Diluted Shares: 48.2M
48.2M
+35.23%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs NNOX
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+>999%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+>999%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+>999%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+>999%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+>999%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+>999%
#7
Nano-X Imaging Ltd.NNOX
Nano-X Imaging Ltd.YOU
64.8M—

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Nano-X Imaging Ltd. (NNOX) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2025, Nano-X Imaging Ltd. reports 64.8M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Nano-X Imaging Ltd.'s basic shares outstanding (64.8M) represents currently issued shares. Diluted shares outstanding (64.8M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

Nano-X Imaging Ltd.'s float is 69.4M (99.7% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float69.4M(99.7%)
Outstanding69.6M

ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

Nano-X Imaging Ltd. (NNOX) shares outstanding history from 2018 to 2025. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Nano-X Imaging Ltd. shares outstanding for the fiscal year ending December 31, 2025 were 64.8M, a 10.52% increase year-over-year. Nano-X Imaging Ltd. FY 2025 shares outstanding were 64.8M, a +10.52% increase from FY 2024.

Nano-X Imaging Ltd. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of — — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.
Market capSplitsEarningsFinancials (Income)Cash on handFree cash flowNet incomePrice history

Frequently asked questions

NNOX shares outstanding · 4 questions

As of December 31, 2025, Nano-X Imaging Ltd. (NNOX) has approximately 64.8M basic shares outstanding and 64.8M diluted shares outstanding. This represents a +10.52% year-over-year increase from FY 2024 (58.6M). The increase may reflect equity compensation issuances or secondary offerings.

NNOX shares outstandinghow many shares does NNOX haveNNOX basic shares 2025NNOX diluted shares

▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Nano-X Imaging Ltd. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-08